Henry ScheinHSIC
About: Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Employees: 25,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
826% more call options, than puts
Call options by funds: $163M | Put options by funds: $17.6M
10% more capital invested
Capital invested by funds: $8.68B [Q1] → $9.58B (+$896M) [Q2]
9% more funds holding in top 10
Funds holding in top 10: 11 [Q1] → 12 (+1) [Q2]
5.83% more ownership
Funds ownership: 102.14% [Q1] → 107.97% (+5.83%) [Q2]
7% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 68
1% less funds holding
Funds holding: 552 [Q1] → 546 (-6) [Q2]
17% less repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 218
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Evercore ISI Group Elizabeth Anderson | 21%upside $83 | Outperform Upgraded | 26 Aug 2025 |
JP Morgan Rachel Vatnsdal | 11%upside $76 | Overweight Maintained | 7 Aug 2025 |
UBS Kevin Caliendo | 2%upside $70 | Neutral Maintained | 6 Aug 2025 |
Evercore ISI Group Ross Muken | 2%upside $70 | In-Line Maintained | 6 Aug 2025 |
Barrington Research Michael Petusky | 14%upside $78 | Outperform Maintained | 6 Aug 2025 |
Financial journalist opinion
Based on 15 articles about HSIC published over the past 30 days
